MARKET

DAWN

DAWN

Day One Biopharmaceuticals, Inc.
NASDAQ
11.75
+0.34
+2.98%
Opening 14:30 02/09 EST
OPEN
11.32
PREV CLOSE
11.41
HIGH
11.77
LOW
11.00
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
13.20
52 WEEK LOW
5.64
MARKET CAP
1.21B
P/E (TTM)
-7.9553
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DAWN last week (0202-0206)?
Weekly Report · 10h ago
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit
The Motley Fool · 5d ago
Weekly Report: what happened at DAWN last week (0126-0130)?
Weekly Report · 02/02 09:25
Day One Biopharmaceuticals price target lowered to $24 from $34 at TD Cowen
TipRanks · 01/29 14:38
Day One Biopharmaceuticals: Buy Rating Reiterated as Updated Ojemda Forecasts and DCF Support Attractive Valuation Despite Lowered Price Target
TipRanks · 01/29 12:25
Best Momentum Stocks to Buy for January 27th
NASDAQ · 01/27 15:00
New Strong Buy Stocks for January 27th
NASDAQ · 01/27 09:16
Weekly Report: what happened at DAWN last week (0119-0123)?
Weekly Report · 01/26 09:24
More
About DAWN
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor. OJEMDA is used for the treatment of patients over six months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. Its pipeline product candidates include DAY301 and Emi-Le (emiltatug ledadotin). DAY301 is a novel Antibody Drug Conjugate, or ADC, targeting protein-tyrosine kinase 7, or PTK7. Emi-Le (emiltatug ledadotin) is a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).

Webull offers Day One Biopharmaceuticals Inc stock information, including NASDAQ: DAWN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DAWN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DAWN stock methods without spending real money on the virtual paper trading platform.